Search filters

List of works by Luisa Carbognin

A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study

scientific article

An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer

scientific article published on 12 June 2015

Avoiding chemotherapy for advanced nononcogene addicted NSCLC overexpressing PD-L1: Rule or option?

scientific article published on 01 June 2018

Balancing activity and tolerability of neoadjuvant paclitaxel- and docetaxel-based chemotherapy for HER2-positive early stage breast cancer: sensitivity analysis of randomized trials

scientific article

Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer

article

Clinical results of randomized trials and 'real-world' data exploring the impact of Bevacizumab for breast cancer: opportunities for clinical practice and perspectives for research.

scientific article

Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer.

scientific article published on 17 November 2015

Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis

scientific article published on 10 March 2016

Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers

scientific article

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

scientific article published on 07 August 2019

Efficacy and safety of T-DM1 in the 'common-practice' of HER2+ advanced breast cancer setting: a multicenter study.

scientific article published on 18 March 2017

Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: A systematic review and an exploratory meta-analysis.

scientific article

HER2/neu gene determination in women screened for breast carcinoma: how screening programs reduce the skyrocketing cost of targeted therapy

article

Human epidermal growth factor receptor 2-positive breast cancer: heat shock protein 90 overexpression, Ki67 proliferative index, and topoisomerase II-α co-amplification as predictors of pathologic complete response to neoadjuvant chemotherapy with t

scientific article

Immune checkpoint inhibitors for non-small-cell lung cancer: does that represent a 'new frontier'?

scientific article

Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trials.

scientific article

Integrating the molecular background of targeted therapy and immunotherapy in lung cancer: a way to explore the impact of mutational landscape on tumor immunogenicity

scientific article

MET exon 14 juxtamembrane splicing mutations: clinical and therapeutical perspectives for cancer therapy

scientific article published on January 2017

Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification

scientific article published on 15 June 2015

Moving towards a customized approach for drug development: lessons from clinical trials with immune checkpoint inhibitors in lung cancer

scientific article

Muscle derangement and alteration of the nutritional machinery in NSCLC

scientific article published on 15 June 2019

Neoadjuvant Chemotherapy In Triple-Negative Breast Cancer: A Multicentric Retrospective Observational Study In Real-Life Setting.

scientific article published on 15 July 2017

Neoadjuvant strategies for triple negative breast cancer: 'state-of-the-art' and future perspectives.

scientific article

Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitors

scientific article published in December 2016

PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: a systematic review and meta-analysis

scientific article published on 03 June 2019

Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience

scientific article published on 10 December 2018

Platelet-derived growth factor receptor inhibitors for non-small cell lung cancer: is the odyssey over?

scientific article published on 25 April 2016

Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Neoadjuvant Setting

scientific article published on 10 February 2016

Prognostic and Predictive Implications of PTEN in Breast Cancer: Unfulfilled Promises but Intriguing Perspectives

scientific article published on 19 September 2019

Prognostic impact of early nutritional support in patients affected by locally advanced and metastatic pancreatic ductal adenocarcinoma undergoing chemotherapy.

scientific article published on 26 March 2018

Putative predictors of efficacy for immune checkpoint inhibitors in non-small-cell lung cancer: facing the complexity of the immune system

scientific article published on 14 October 2017

Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story

scientific article published on 10 October 2019

Risk Stratification Model for Resected Squamous-Cell Lung Cancer Patients According to Clinical and Pathological Factors

scientific article published on 20 July 2015

Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer

scientific article published on 22 March 2016

T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer

scientific article published on 12 July 2018

The coming of ramucirumab in the landscape of anti-angiogenic drugs: potential clinical and translational perspectives.

scientific article published on 20 July 2015

The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinoma

scientific article published on 28 July 2013

The obesity paradox in cancer: clinical insights and perspectives

scientific article published on 28 February 2018

Tracking MET de-addiction in lung cancer: A road towards the oncogenic target.

scientific article published on 20 August 2017

Tubulin inhibitors in non-small cell lung cancer: looking back and forward

scientific article published on 21 February 2016

Tumor-infiltrating lymphocytes in breast cancer according to tumor subtype: Current state of the art.

scientific article

Paulina is supported by:

About Paulina

Help